This extended release tablet consists of two layers
Sleeping pills in the US market, valued at 2 billion dollars per year, is in full upheaval. So far, Sanofi-Aventis undoubtedly prevailed to a market share of over 90, with its drug Ambien, the Stilnox American version...
